PATENT CLAIM ANALYSIS

Application Number: 15778368
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "218100"]

Abstract:
A highly safe dengue vaccine was invented that induced a neutralizing antibody response against all of the four serotypes of dengue virus without developing more than a fixed level of viremia with single administration. A tetravalent dengue virus formulation is provided that is excellent in both efficacy (neutralizing antibody response) and safety (viremia).

Claim (Index 21):
An attenuated serotype 3 dengue virus wherein said virus has homology of 95% or more with serotype 3 dengue virus parent strain 16562 having an amino acid sequence of SEQ ID NO: 3 as analyzed using a Next Generation Sequencer, has complete mutation at any one of amino acid residue at position 209, 582, 1211 or 1563 of said parent strain, and further has one or more mutations of the following (7) to (10):\n (7) K/R671K (8) A687V (9) T764I/T (10) A1237T.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.37209
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15195820', '11449876', '11453344', '13212845', '13281240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7416309107177316
- 35 USC 102 Novelty (BERT): 0.5440329221242994
- Combined Prediction Score: 0.7218711118583884
- Mean Citation Score: 370.044854
- Max Citation Score: 379.45105
- Similarity Product: 276.9501495156169

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test